Moderna, Inc. United States revenue
United States revenue at Moderna, Inc. came to $1.2B for the fiscal year to 31 Dec 2025, down 32.8% from a year earlier.
As Moderna, Inc. reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 20 Feb 2026.
By fiscal year
| Period ending | United States revenue | Change on a year | Filed |
|---|---|---|---|
| 31 Dec 2025 | $1.2B | down 32.8% | 20 Feb 2026 |
| 31 Dec 2024 | $1.8B | down 5.8% | 21 Feb 2025 |
| 31 Dec 2023 | $1.9B | down 63.2% | 23 Feb 2024 |
| 31 Dec 2022 | $5.2B | down 16.6% | 24 Feb 2023 |
| 31 Dec 2021 | $6.2B | up 708.5% | 25 Feb 2022 |
| 31 Dec 2020 | $764.0M | up 1289.1% | 26 Feb 2021 |
| 31 Dec 2019 | $55.0M | down 38.3% | 27 Feb 2020 |
| 31 Dec 2018 | $89.1M | — | 13 Mar 2019 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Moderna, Inc.: COVID revenue · Stand-ready manufacturing revenue · RSV revenue · Collaboration Arrangement, Including Arrangements With Affiliate revenue · Grant revenue · Rest of world revenue · Europe revenue · financial statements
Every KPI and segment of MRNA, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
